New immunotherapy shows promise in fighting resistant pancreatic cancer
Labiotech - 04-May-2023IMAN therapy targets tumours and activates the immune system against tough-to-treat cancers
Join the club for FREE to access the whole archive and other member benefits.
Founder and Chief Executive Officer of LIfT BioSciences
Serial entrepreneur with 15 years’ experience in commercialising novel biopharma assets and strategy consulting, having advised teams and led the strategic planning for bringing to market over 50 assets for companies like Pfizer, Allergan, abbVie, Amgen, Shire, Takeda, GSK & Sanofi. Founded the company after losing his mother to Pancreatic Cancer, and seeing a new way to beat cancer by utilising the innate immune system.
Visit website: https://www.liftbiosciences.com/our-staff
See also: LIfT BioSciences - Biotechnology company that develops a portfolio of potentially life-saving immuno-oncology cell therapies
Details last updated 01-May-2020
Biotechnology company that develops a portfolio of potentially life-saving immuno-oncology cell therapies
IMAN therapy targets tumours and activates the immune system against tough-to-treat cancers
N-LIfT is an allogenic cell therapy which recruits patient's own immune cells against cancers
Uses cancer-killing cells from people with the strongest immune systems. Neutrophil cells form p...